XML 58 R17.htm IDEA: XBRL DOCUMENT v3.3.0.814
Earnings Per Share
9 Months Ended
Sep. 30, 2015
Earnings Per Share  
Earnings (loss) Per Share

Note 10 – Earnings Per Share

 

The earnings per share – both basic and diluted – are included below as of September 30 (in thousands except for share data):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended September 30, 

 

Nine Months Ended

September 30, 

 

    

2015

    

2014

    

2015

    

2014

Basic earnings per share:

 

 

 

 

 

 

 

 

 

 

 

 

Weighted-average common shares outstanding

 

 

29,478,429

 

 

29,442,508

 

 

29,474,833

 

 

23,905,205

Weighted-average common shares less stock based awards

 

 

29,478,429

 

 

29,442,508

 

 

29,474,833

 

 

23,902,403

Weighted-average common shares stock based awards

 

 

 -

 

 

325,000

 

 

 -

 

 

225,232

Net income

 

$

3,924

 

$

2,924

 

$

11,552

 

$

7,147

Gain on preferred stock redemption

 

 

 -

 

 

 -

 

 

 -

 

 

(1,348)

Preferred stock dividends and accretion, net of dividends waived

 

 

339

 

 

1,065

 

 

1,873

 

 

(1,448)

Net earnings available to common stockholders

 

 

3,585

 

 

1,859

 

 

9,679

 

 

9,943

Basic earnings per share common undistributed earnings

 

 

N/A

 

 

0.06

 

 

N/A

 

 

0.41

Basic earnings per share

 

 

0.12

 

 

0.06

 

 

0.33

 

 

0.41

Diluted earnings per share:

 

 

 

 

 

 

 

 

 

 

 

 

Weighted-average common shares outstanding

 

 

29,478,429

 

 

29,442,508

 

 

29,474,833

 

 

23,905,205

Dilutive effect of nonvested restricted awards1

 

 

268,000

 

 

325,000

 

 

249,401

 

 

222,430

Diluted average common shares outstanding

 

 

29,746,429

 

 

29,767,508

 

 

29,724,234

 

 

24,127,635

Net earnings available to common stockholders

 

$

3,585

 

$

1,859

 

$

9,679

 

$

9,943

Diluted earnings per share

 

$

0.12

 

$

0.06

 

$

0.33

 

$

0.41

 

 

 

 

 

 

 

 

 

 

 

 

 

Number of antidilutive options and warrants excluded from the diluted earnings per share calculation

 

 

1,044,339

 

 

1,140,839

 

 

1,044,339

 

 

1,140,839

 

 

 

 

 

 

 

 

 

 

 

 

 

1 Includes the common stock equivalents for restricted share rights that are dilutive.

 

 

 

 

 

 

 

 

 

 

 

 

 

The above earnings per share calculation did not include a warrant for 815,339 shares of common stock, at an exercise price of $13.43 per share, that was outstanding as of September 30, 2015, and September 30, 2014, because the warrant was anti-dilutive.   Of note, the warrant was sold at auction by the Treasury in June 2013 to a third party investor.

 

The Company completed the redemption of 25,669 shares of its Fixed Rate Cumulative Perpetual Preferred Stock, Series B (the “Series B Stock”) in the second quarter of 2014.  As previously disclosed, the Company completed a public offering of 15,525,000 shares of common stock in April of 2014.  Net proceeds of over $64.0 million were used to pay the accrued but unpaid interest on the Company’s  trust preferred securities or junior subordinated debentures discussed in Note 8, the accumulated but unpaid dividends on the Series B Stock and to complete the 2014 redemption of the Series B Stock.  The amount remaining after the completion of these transactions was retained at the Company for use in addressing general corporate matters.  The redemption price for such Series B Stock was 94.75% of the liquidation value of the shares and the holders of the redeemed shares agreed to forebear payment of dividends due and waived any rights to such dividend upon redemption.  The Company redeemed all shares of Series B Stock held by directors of the Company on the same terms.

 

On January 31, 2015, the Company redeemed 15,778 shares of its Series B Stock at a redemption price equal to the stated liquidation value of $1,000 per share, together with accrued and unpaid dividends accumulated to, but excluding, the redemption date. As of December 30, 2014, there were 47,331 shares of the Series B Stock outstanding, and redeeming one-third of the Series B Stock resulted in the redemption of 15,778 shares of Series B Stock.  The redemption was successfully completed in the first quarter.

 

In July 2015, the Company announced that it would redeem the remaining 31,553 outstanding shares of Series B Stock on August 14, 2015 at the redemption price, equal to the stated liquidation value of $1,000 per share, together with any accrued and unpaid dividends accumulated to, but excluding, the redemption date.  The redemption was successfully completed in the third quarter.  As of September 30, 2015, no shares of the Series B Stock remained outstanding.  Please see the Capital section of Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations capital section for further information on this topic.